WIXOM, Mich., March 7, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today that it will hold an investor conference call on Monday, March 18, 2013 at 4:30 pm ET to discuss its fourth quarter and 2012 year end results. Robert Chioini, Chairman and CEO, and Thomas Klema, CFO, will be hosting the call to review Rockwell's results. Rockwell will be releasing its earnings results on the same date following the market close.
|Date: March 18, 2013|
|Time: 4:30 PM ET|
|Listen via Internet: http://ir.rockwellmed.com/|
|Schedule this webcast into MS-Outlook calendar (click open when prompted):|
|Telephone: (877) 383-7438|